134 results
Thumbnail

D3.291 - Hereditary angioedema with normal C1Inh and PLG mutation treated with tranexamic acid : Beware of the risk of thrombosis

Thumbnail

D3.292 - "Evaluating Inflammatory Markers in Chronic Spontaneous Urticaria: Impact of Omalizumab Treatment"

Thumbnail

D3.293 - Acrodermatitis chronica atrophicans in the field of scleroderma

Thumbnail

D3.295 - Mental health support for atopic dermatitis patients in the Republic of Kazakhstan

Thumbnail

D3.296 - Urticaria activity, quality of life and disease control in chronic spontaneous urticaria patients in Kazakhstan

Thumbnail

D3.298 - Monomorphic maculo-papular late age onset cutaneous mastocytosis

Thumbnail

D3.299 - Cholinergic urticaria treated with dupilumab

Thumbnail

D3.30 - Fixed drug eruption: exploring diagnostic considerations and triggers in a cohort study

Thumbnail

D3.302 - Elevated Kocuria rhizophila contributing to repair of skin barrier function in patients with atopic dermatitis

Thumbnail

D3.303 - Contact Dermatitis and Rhinoconjunctivitis due to Palisander Wood Exposure in a Cabinetmaker

Thumbnail

D3.304 - Monitoring skin inflammation in atopic dermatitis by non-invasive sampling through skin tape stripping for multiplex protein analysis is complementary to serum biomarkers

Thumbnail

D3.305 - Pediatric and Adult Responses to Fourth-Fold Antihistamine Doses: Insights into Efficacy and Safety

Thumbnail

D3.306 - Successful treatment of severe atopic dermatitis in teenage patient with hyper-IgE syndrome (STAT3 mutation)

Thumbnail

D3.307 - Experience with Systemic Emergent Therapies for Moderate-to-Severe Atopic Dermatitis: Insights from an Allergy and Clinical Immunology Department

Thumbnail

D3.308 - Frailty in elderly with C1 Inhibitor Hereditary Angioedema: first evidence from a monocentric ITACA cohort

Thumbnail

D3.309 - Challenges in HAE therapy in children

Thumbnail

D3.31 - Successful Management of Primary Cold Urticaria in Medical Practitioners: A Small Case Series

Thumbnail

D3.310 - Hereditary angioedema (HAE) with factor XIIa mutation successfully treated with icatibant as on-demand therapy and lanadelumab for long-term prophylaxis

Thumbnail

D3.311 - Screening for Hereditary Angioedema in Pediatric Patients with Autoinflammatory Diseases and Chronic Abdominal Pain

Thumbnail

D3.312 - Lymphatic supplementation improves atopic dermatitis in dogs